New Diagnostic Biomarker Test Shows Promise in Monitoring Ovarian Cancer

Ovarian malignancies are a leading cause of cancer death in women because they are usually detected in the late stages when the disease is incurable. Encouraging new research presented by Abbott shows that a novel diagnostic marker, combined with other tests, can be used to more effectively monitor for early-stage ovarian cancer.

HHS Makes Recovery Act Funding Available to Expand Health Professions Training

HHS Secretary Kathleen Sebelius today announced the availability of $200 million to support grants, loans, loan repayment, and scholarships to expand the training of health care professionals. The funds are expected to train approximately 8,000 students and credentialed health professionals by the end of fiscal year 2010.

Analysis: Who Pays for Health Care Reform?

Senate Majority Leader Harry Reid (D-Nev) has conceded that the Senate will not pass a health care reform bill before the August Congressional recess. Meanwhile, House officials have not ruled out a special session that would spill over into the heart of Summer.

Agilent Technologies to Acquire Varian

Agilent Technologies Inc and Varian Inc today announced that they have signed a definitive agreement for the acquisition by Agilent of Varian, a worldwide supplier of scientific instrumentation and associated consumables for life science and applied market applications.

New Lab Test Helps Predict Kidney Damage

Acute kidney injury (AKI) is a frequent complication in patients in intensive care. A new laboratory test called urine neutrophil gelatinase associated lipocalin (NGAL) helps predict if patients will develop acute kidney injury, reports an upcoming study.